
News|Articles|October 25, 2022
AAPS 2022 Conference Highlights
Author(s)Alivia Leon
Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Com, discuss cell & gene therapies and co-processed APIs respectively.
Advertisement
At the AAPS 2022 conference in Boston, Pharmaceutical Technology interviewed Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Co. We spoke with Vibha Jawa about her expertise in the field of cell & gene therapies, specifically CAR-T cells. Luke Schenck discussed his knowledge on co-processed APIs. To see the highlights of our interviews with these experts, click the video below.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—June 5, 2026
2
A Pharma Manufacturing Blueprint from Delaware’s Innovation Vision
3
EMA Collaborates with African Regulators on Ebola Treatments
4
Renewing Prosaic Generics for Cancer Treatment
5




